Commercial insight into the pharma and biotech sector.

Solutions for Buy Side Investment Professionals

Your investment performance depends on your insights being more informed than those of the market. EvaluatePharma provides a unique solution with cutting-edge analysis and innovative perspectives to help position you ahead of key events, increasing your competitive edge in identifying new investment opportunities and evaluating your current holdings.

  • Track the market consensus so you can trade where your view is different from that of the market with the latest consensus view in intricate detail for each company, product & therapy area
  • Exploit anomalies in market valuations with standardized, in-depth forecast company financial models linked to daily, forward-looking valuation measures that can be sifted, filtered and tied back to industry and product fundamentals 
  • Simplify event driven trading strategies with our innovative Calendar of Events tracking & analysing all future pivotal events that may impact company valuations, including product approvals, clinical trials, patent & litigation
  • Model the potential impact of industry events on share prices with our interactive NPV Analyzer with over 3100 global product NPVs

Find out more Download Solutions for Buy Side Investment Professionals

Register for access to a selection of free analysis and insights 


Exclusive Analysis & Insights

Global Market Analytics             Financial Information
Product Forecasts to 2016        Sales by Indication
Partnering Opportunities   Archived Sales Forecasts
Drug Information                         R&D Pipeline
Clinical Trials                     Venture Financing

Exclusive Analysis & Insights

Licensing Deals                               M&A Activity 
Patent Risk                                       NPV Analyzer
EP Vantage & EventAnalyzer          Calendar of Events
NewsManager                                 Peer Group Analyzer
Merge Company & Company Rank